https://pubmed.ncbi.nlm.nih.gov/31012964/
Activating p53 family member TAp63: A novel therapeutic strategy for targeting p53-altered tumors
The miR-130b/TAp63 axis is proposed as a new druggable pathway that has the potential to uncover broad-spectrum therapeutic options for the majority of...